Lemaitre Vascular (LMAT) Other Accumulated Expenses (2012 - 2026)

Lemaitre Vascular (LMAT) has 15 years of Other Accumulated Expenses data on file, last reported at $1.3 million in Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $1.3 million, up 241.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (up 241.33% YoY), and the FY2025 annual result was $546000.0, up 26.68% from the prior year.
• Other Accumulated Expenses grew to $1.3 million in Q1 2026 per LMAT's latest filing, from $546000.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $6.1 million in Q2 2022 and troughed at $119000.0 in Q3 2022.
• A 5-year average of $1.0 million and a median of $431000.0 in 2024 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2026: Other Accumulated Expenses slumped 97.78% in 2022, then surged 241.33% in 2026.
• A 5-year view of Other Accumulated Expenses shows it stood at $252000.0 in 2022, then surged by 58.73% to $400000.0 in 2023, then increased by 7.75% to $431000.0 in 2024, then rose by 26.68% to $546000.0 in 2025, then jumped by 145.05% to $1.3 million in 2026.
• Business Quant data shows LMAT's Other Accumulated Expenses at $1.3 million in Q1 2026, $546000.0 in Q4 2025, and $438000.0 in Q3 2025.